Literature DB >> 8122295

Mass spectrometric investigations of drug-receptor interactions.

J Henion1, Y T Li, Y L Hsieh, B Ganem.   

Abstract

Mass spectrometric (MS) detection of biologically important noncovalent complexes is reviewed within the scope of on-going studies on this topic from this laboratory. The merits of ion spray MS and tandem MS are demonstrated in this area with examples that show systemic studies of several receptor-ligand, enzyme-substrate, and enzyme-product complexes associated with both an established well-characterized biological system (lysozyme hydrolysis of N-acetylglucosamine) and an important modern receptor-ligand complex (FKBP-FK-506 and FKBP-rapamycin). These examples and recent applications of negative ion MS and MS/MS with DNA adducts, heme-globin complexes, and antibiotic-binding proteins suggest an exciting new area of applications for MS that have not been previously available to investigators.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8122295     DOI: 10.1097/00007691-199312000-00020

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  3 in total

1.  Spinning up mass spectrometry for whole protein complexes.

Authors:  Philip D Compton; Neil L Kelleher
Journal:  Nat Methods       Date:  2012-11       Impact factor: 28.547

2.  Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics.

Authors:  Ting Zhang; Zhiqiang Wu; Jiang Du; Yongfeng Hu; Liguo Liu; Fan Yang; Qi Jin
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

3.  From molecular chaperones to membrane motors: through the lens of a mass spectrometrist.

Authors:  Carol V Robinson
Journal:  Biochem Soc Trans       Date:  2017-02-08       Impact factor: 5.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.